You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Axumin

Showing 1 - 25 of 36
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Brain Metastases Trial in Houston (18F-Fluciclovine (Axumin), Pet Scan)

Not yet recruiting
  • Brain Metastases
  • 18F-Fluciclovine (Axumin)
  • Pet Scan
  • Houston, Texas
    M D Anderson Cancer Center
Aug 23, 2023

Malignant Tumor of Prostate Trial in Cleveland ([F-18] NaF PET/CT, [F-18] fluciclovine PET/CT)

Withdrawn
  • Malignant Neoplasm of Prostate
  • [F-18] NaF PET/CT
  • [F-18] fluciclovine PET/CT
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Mar 21, 2022

Prostate Cancer Trial in Portland (Fluciclovine PET/CT)

Not yet recruiting
  • Prostate Cancer
  • Fluciclovine PET/CT
  • Portland, Oregon
    Oreogn Health & Science University
Feb 1, 2023

Glioma Glioblastoma Multiforme Trial in Philadelphia (Axumin, Intravenous Solution)

Completed
  • Glioma Glioblastoma Multiforme
  • Axumin, Intravenous Solution
  • Philadelphia, Pennsylvania
    Hospital of the University of Pennsylvania
Dec 21, 2021

Role of Axumin PET Scan in Germ Cell Tumor

Active, not recruiting
  • Testis Cancer
  • +12 more
  • Axumin PET scan
  • Dallas, Texas
    UT Southwestern Medical Center
Nov 5, 2021

Prostate Adenocarcinoma Trial in Tucson (F-18 fluciclovine-PET/CT scan)

Completed
Has Results
  • Prostate Adenocarcinoma
  • F-18 fluciclovine-PET/CT scan
  • Tucson, Arizona
    University of Arizona
Aug 12, 2022

Glioma, High Grade Glioma, Glioma, Malignant Trial in Philadelphia (18F-Fluciclovine PET-MRI)

Recruiting
  • Glioma
  • +4 more
  • 18F-Fluciclovine PET-MRI
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Dec 22, 2022

Advanced Prostate Cancer, Metastatic Prostate Cancer, Metastatic Prostate Neuroendocrine Carcinoma Trial in Boston

Not yet recruiting
  • Advanced Prostate Cancer
  • +2 more
  • Boston, Massachusetts
  • +1 more
Sep 25, 2023

Brain Tumor, Recurrent, Adult Trial in Loma Linda (PET/CT with F-Fluciclovine (Axumin))

Recruiting
  • Brain Tumor, Recurrent, Adult
  • PET/CT with F-Fluciclovine (Axumin)
  • Loma Linda, California
    Loma Linda University Cancer Center
Sep 20, 2021

Brain Metastases, Brain Metastases, Adult, Brain Cancer Trial in Miami (18F fluciclovine)

Not yet recruiting
  • Brain Metastases
  • +2 more
  • 18F fluciclovine
  • Miami, Florida
    Miami Cancer Institute
Sep 15, 2023

Prostate Cancer, Prostate Nodule Trial in Houston (18F-fluciclovine)

Not yet recruiting
  • Prostate Cancer
  • Prostate Nodule
  • 18F-fluciclovine
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Feb 14, 2022

Grade III or Grade IV Glioma Trial (PET imaging with 18F fluciclovine)

Not yet recruiting
  • Grade III or Grade IV Glioma
  • PET imaging with 18F fluciclovine
  • (no location specified)
Jul 27, 2022

Glioma, Low-grade Glioma, Low Grade Glioma of Brain Trial in Philadelphia (18F-Fluciclovine)

Not yet recruiting
  • Glioma
  • +4 more
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Oct 3, 2022

Prostate Cancer Trial in New York (Standard of Care MRI, Fluciclovine PET scan added to MRI)

Completed
  • Prostate Cancer
  • Standard of Care MRI
  • Fluciclovine PET scan added to MRI
  • New York, New York
    NYU Langone Health
Mar 29, 2021

Bladder Cancer, Urothelial Carcinoma Trial in Boston (18F-fluciclovine, PET/CT)

Recruiting
  • Bladder Cancer
  • Urothelial Carcinoma
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Apr 4, 2022

Brain Metastases, Adult, Brain Metastases, Brain Cancer Trial in Miami (18F fluciclovine)

Recruiting
  • Brain Metastases, Adult
  • +2 more
  • 18F fluciclovine
  • Miami, Florida
  • +1 more
Apr 11, 2022

Pancreatitis, Graft, Pancreatic Transplant Post-Transplant Dysfunction Rejection Trial in Salt Lake City (18F-fluciclovine)

Enrolling by invitation
  • Pancreatitis, Graft
  • Pancreatic Transplant Post-Transplant Dysfunction Rejection
  • Salt Lake City, Utah
    University of Utah Hospital
Sep 27, 2021

Metastatic Castration-resistant Prostate Cancer Trial in New Orleans (18F-fluciclovine PET Scan)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • 18F-fluciclovine PET Scan
  • New Orleans, Louisiana
    Tulane Cancer Center Clinic
Oct 8, 2021

Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Houston (Computed Tomography, Fluciclovine F18,

Terminated
  • Metastatic Prostate Carcinoma
  • Stage IVB Prostate Cancer AJCC v8
  • Computed Tomography
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

18F-fluciclovine PET/MRI Imaging for Detection of Tumor

Suspended
  • Metastatic Intracranial Malignant Neoplasm
  • Recurrent Intracranial Neoplasm
  • Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Positron Emission Tomography
  • Fluciclovine F18
  • Jacksonville, Florida
    Mayo Clinic in Florida
Dec 27, 2021

Prostate Cancer Trial in Los Angeles (18F-Fluciclovine)

Completed
Has Results
  • Prostate Cancer
  • Los Angeles, California
    Cedars-Sinai Medical Center
Feb 2, 2021

Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Squamous Cell Carcinoma in Cervical Lymph Node Trial in Houston

Active, not recruiting
  • Metastatic Head and Neck Squamous Cell Carcinoma
  • Metastatic Squamous Cell Carcinoma in Cervical Lymph Node
  • Computed Tomography
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2022

Cervical Cancer, Uterine Cancer Trial in Pittsburgh (18F fluciclovine, 18F fluciclovine PET)

Terminated
Has Results
  • Cervical Cancer
  • Uterine Cancer
  • 18F fluciclovine
  • 18F fluciclovine PET
  • Pittsburgh, Pennsylvania
    UPMC Presbyterian - MR Research Center
Oct 6, 2020

Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Lobular Carcinoma, Metastatic Breast Lobular Carcinoma Trial in Atlanta

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +3 more
  • Computed Tomography
  • +3 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Aug 9, 2022

Stage II Nasopharyngeal Carcinoma AJCC v8, Stage III Nasopharyngeal Carcinoma AJCC v8, Stage IV Nasopharyngeal Carcinoma AJCC v8

Not yet recruiting
  • Stage II Nasopharyngeal Carcinoma AJCC v8
  • +2 more
  • Biopsy
  • +16 more
  • (no location specified)
Oct 7, 2023